These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34502328)
1. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles. Noor NS; Kaus NHM; Szewczuk MR; Hamid SBS Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502328 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. Ahmad R; Kaus NHM; Hamid S Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443 [TBL] [Abstract][Full Text] [Related]
3. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties, Shaarani S; Hamid SS; Mohd Kaus NH Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648 [TBL] [Abstract][Full Text] [Related]
4. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization. Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807 [TBL] [Abstract][Full Text] [Related]
5. Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells. Ibrahim WN; Muizzuddin Bin Mohd Rosli L; Doolaanea AA Int J Nanomedicine; 2020; 15():8059-8074. PubMed ID: 33116518 [TBL] [Abstract][Full Text] [Related]
7. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles. Ganea GM; Fakayode SO; Losso JN; van Nostrum CF; Sabliov CM; Warner IM Nanotechnology; 2010 Jul; 21(28):285104. PubMed ID: 20585163 [TBL] [Abstract][Full Text] [Related]
8. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles. Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells. Jin C; Bai L; Wu H; Song W; Guo G; Dou K Pharm Res; 2009 Jul; 26(7):1776-84. PubMed ID: 19384463 [TBL] [Abstract][Full Text] [Related]
10. Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458 [TBL] [Abstract][Full Text] [Related]
11. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer. Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698 [TBL] [Abstract][Full Text] [Related]
12. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer. Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T Front Chem; 2023; 11():1044953. PubMed ID: 36846852 [TBL] [Abstract][Full Text] [Related]
13. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells. Devulapally R; Sekar TV; Paulmurugan R Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells. Diab T; Alkafaas SS; Shalaby TI; Hessien M Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment. Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
17. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced. Song X; Wang J; Xu Y; Shao H; Gu J Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]